Search research articles
Contact Us
Filters
Showing results (281-290 of 368) with videos related to
Page
of 37
Sort By:
Gastroenterologie Clinique Et Biologique
|
January 1, 1990
[Transhepatic embolization and endoscopic sclerosing in digestive hemorrhage caused by rupture of esophageal varices in patients with Child's stage C cirrhosis]
P Bonnière, M Henry-Amar, D Lescut, et al.
Gastroenterologie Clinique Et Biologique
|
January 1, 1992
[Digestive lymphomatous polyposis]
A Ruskoné-Fourmestraux, P Pescatore, J C Rambaud, et al.
Scandinavian Journal of Gastroenterology. Supplement
|
January 1, 1989
Incidence of inflammatory bowel disease in northwestern France. Preliminary results in region Nord-Pas-de-Calais
J F Colombel, J L Salomez, A Cortot, et al.
Scandinavian Journal of Gastroenterology
|
November 15, 1997
TAP gene transporter polymorphism in inflammatory bowel diseases
D Heresbach, M Alizadeh, J F Bretagne, et al.
Alimentary Pharmacology & Therapeutics
|
September 19, 2015
Randomised clinical study: discrepancies between patient-reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis
B Jharap, W J Sandborn, W Reinisch, et al.
Alimentary Pharmacology & Therapeutics
|
March 20, 2010
Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's disease
R Panaccione, J-F Colombel, W J Sandborn, et al.
Gut
|
May 1, 1993
Perioperative endoscopy of the whole small bowel in Crohn's disease
D Lescut, D Vanco, P Bonnière, et al.
Alimentary Pharmacology & Therapeutics
|
August 28, 2003
Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine
B Bonaz, J Boitard, P Marteau, et al.
Gastroenterology
|
October 1, 1988
Massive plasma cell infiltration of the digestive tract. Secretory component as the rate-limiting factor of immunoglobulin secretion in external fluids
J F Colombel, J C Rambaud, J P Vaerman, et al.
Journal of Crohn'S & Colitis
|
June 19, 2012
Subgroup analysis of the placebo-controlled CHARM trial: increased remission rates through 3 years for adalimumab-treated patients with early Crohn's disease
S Schreiber, W Reinisch, J F Colombel, et al.
Page
of 37
Search research articles
Search
Showing results (281-290 of 368) with videos related to
Sort By:
Page
of 37
Gastroenterologie Clinique Et Biologique
|
January 1, 1990
[Transhepatic embolization and endoscopic sclerosing in digestive hemorrhage caused by rupture of esophageal varices in patients with Child's stage C cirrhosis]
P Bonnière, M Henry-Amar, D Lescut, et al.
Gastroenterologie Clinique Et Biologique
|
January 1, 1992
[Digestive lymphomatous polyposis]
A Ruskoné-Fourmestraux, P Pescatore, J C Rambaud, et al.
Scandinavian Journal of Gastroenterology. Supplement
|
January 1, 1989
Incidence of inflammatory bowel disease in northwestern France. Preliminary results in region Nord-Pas-de-Calais
J F Colombel, J L Salomez, A Cortot, et al.
Scandinavian Journal of Gastroenterology
|
November 15, 1997
TAP gene transporter polymorphism in inflammatory bowel diseases
D Heresbach, M Alizadeh, J F Bretagne, et al.
Alimentary Pharmacology & Therapeutics
|
September 19, 2015
Randomised clinical study: discrepancies between patient-reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis
B Jharap, W J Sandborn, W Reinisch, et al.
Alimentary Pharmacology & Therapeutics
|
March 20, 2010
Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's disease
R Panaccione, J-F Colombel, W J Sandborn, et al.
Gut
|
May 1, 1993
Perioperative endoscopy of the whole small bowel in Crohn's disease
D Lescut, D Vanco, P Bonnière, et al.
Alimentary Pharmacology & Therapeutics
|
August 28, 2003
Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine
B Bonaz, J Boitard, P Marteau, et al.
Gastroenterology
|
October 1, 1988
Massive plasma cell infiltration of the digestive tract. Secretory component as the rate-limiting factor of immunoglobulin secretion in external fluids
J F Colombel, J C Rambaud, J P Vaerman, et al.
Journal of Crohn'S & Colitis
|
June 19, 2012
Subgroup analysis of the placebo-controlled CHARM trial: increased remission rates through 3 years for adalimumab-treated patients with early Crohn's disease
S Schreiber, W Reinisch, J F Colombel, et al.
Page
of 37